| 14.97 Delayed Data As of Jul 19 |  +0.01 / +0.07%Today’s Change | 5.61 Today|||52-Week Range 25.10 | +44.08% Year-to-Date |
| Previous close | 14.96 |
| Today’s open | 14.97 |
| Day’s range | 14.86 - 15.33 |
| Volume | 3,626,853 |
| Average volume (3 months) | 5,832,738 |
| Market cap | $5.0B |
| Earnings growth (last year) | -651.95% |
| Earnings growth (this year) | +771.85% |
| Earnings growth (next 5 years) | +5.42% |
| Revenue growth (last year) | +80.42% |
| P/E ratio | 51.5 |
| Price/Sales | 319.68 |
| Price/Book | 17.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | -2.49 | -1.65% |
| ACBAurora Cannabis Inc | -0.11 | -1.58% |
| APHAAphria Inc | -0.06 | -0.93% |
| USNAUSANA Health Science... | +0.03 | +0.05% |
| Next reporting date | August 8, 2019 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $5.7M |
| Annual profit (last year) | -$14.6M |
| Net profit margin | -257.95% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Gorenstein |
Chief Operating Officer David Hsu |
Corporate headquarters Toronto, Ontario |
